Results 161 to 170 of about 228,187 (396)

The Myositis Autoantibody Phenotypes of the Juvenile Idiopathic Inflammatory Myopathies

open access: yesMedicine, 2013
The juvenile idiopathic inflammatory myopathies (JIIM) are systemic autoimmune diseases characterized by skeletal muscle weakness, characteristic rashes, and other systemic features.
L. Rider   +6 more
semanticscholar   +1 more source

Distribution of Certain Autoantibodies in Monozygotic and Dizygotic Twins [PDF]

open access: bronze, 1966
W. Watson Buchanan   +6 more
openalex   +1 more source

B cell reductive therapy with rituximab in the treatment of rheumatoid arthritis. [PDF]

open access: yes, 2009
The approach to treating autoimmune disorders is currently undergoing a significant change in focus. As therapies are developed that are more precise in targeting the pathogenesis for these diseases, patients experience significantly fewer side effects ...
Sands, Jacob, Tuscano, Joseph M
core   +2 more sources

Label‐Free Photonic Biosensors: Key Technologies for Precision Diagnostics

open access: yesChemistryEurope, EarlyView.
Photonic biosensors are versatile technologies promising unique advantages to improve current diagnosis workflows. On‐going research is directed to systems integration and automation as well as enhancing assay performance. Advances in bioengineering, material sciences, and photonics engineering will be the key toward their eventual implementation as ...
Maria Soler, Laura M. Lechuga
wiley   +1 more source

THE THYROID CYTOTOXIC AUTOANTIBODY [PDF]

open access: bronze, 1962
Ian J. Forbes   +3 more
openalex   +1 more source

Confirmation of Fixed Quarterly Riliprubart Regimen in Patients with Cold Agglutinin Disease Using Population PK/PD and Exposure‐Response Analyses

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Riliprubart is a second‐generation, humanized immunoglobulin G4 that inhibits only the activated form of the C1s component of the proximal classical complement pathway. The clinical studies of riliprubart conducted thus far for the treatment of cold agglutinin disease (CAD), a rare autoimmune disease, include a Phase 1 first‐in‐human study in healthy ...
Timothy Chow   +3 more
wiley   +1 more source

MHC associations with clinical and autoantibody manifestations in European SLE

open access: yesGenes and Immunity, 2014
Systemic lupus erythematosus (SLE) is a clinically heterogeneous disease affecting multiple organ systems and characterized by autoantibody formation to nuclear components.
D. Morris   +22 more
semanticscholar   +1 more source

CARDIAC AUTOANTIBODIES [PDF]

open access: bronze, 1968
Seymour P. Halbert   +2 more
openalex   +1 more source

Environment, Autoantibodies, and Autoimmunity [PDF]

open access: yesFrontiers in Immunology, 2015
Susceptibility to autoimmune disease is multifactorial and includes genetic predisposition, gender, ethnicity, age, and environment. While no single factor has been identified as preeminent, the role of the environment has garnered increasing interest.
openaire   +4 more sources

Immune Checkpoint Inhibitors and Cardiovascular Adverse Events

open access: yesESC Heart Failure, EarlyView.
Abstract In the last years, we assisted to a tremendous increase in therapeutic options for the management of cancers, with immunotherapy at the forefront of this innovation. Immune checkpoint inhibitors (ICIs) have been developed to enhance the activity of the immune system against cancer cells (1) and the number of approvals for ICIs has rapidly ...
Maria Luisa De Perna   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy